Insider Transactions in Q2 2018 at Lexicon Pharmaceuticals, Inc. (LXRX)
Insider Transaction List (Q2 2018)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 28
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
57,724
+1.62%
|
$692,688
$12.45 P/Share
|
Jun 27
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
125,114
+3.49%
|
$1,501,368
$12.54 P/Share
|
Jun 25
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
228,264
+6.41%
|
$2,739,168
$12.95 P/Share
|
Jun 22
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
25,461
+0.81%
|
$330,993
$13.36 P/Share
|
Jun 21
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
51,600
+1.65%
|
$670,800
$13.27 P/Share
|
Jun 20
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
12,391
+0.41%
|
$161,083
$13.28 P/Share
|
Jun 19
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
8,982
+0.3%
|
$116,766
$13.45 P/Share
|
Jun 18
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
36,584
+1.2%
|
$475,592
$13.06 P/Share
|
Jun 14
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
9,200
+0.31%
|
$110,400
$12.66 P/Share
|
Jun 12
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
107,023
+3.49%
|
$1,284,276
$12.83 P/Share
|
Jun 11
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
98,626
+3.34%
|
$1,183,512
$12.75 P/Share
|
Jun 08
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
29,747
+1.07%
|
$356,964
$12.89 P/Share
|
Jun 07
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
57,439
+2.06%
|
$689,268
$12.93 P/Share
|
Jun 06
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
95,079
+3.44%
|
$1,140,948
$12.58 P/Share
|
Jun 05
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
173,121
+6.3%
|
$2,077,452
$12.45 P/Share
|
Jun 04
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
121,803
+4.83%
|
$1,461,636
$12.24 P/Share
|
Jun 01
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+6.07%
|
$1,768,068
$12.22 P/Share
|
May 31
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+6.47%
|
$1,620,729
$11.62 P/Share
|
May 30
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+6.92%
|
$1,473,390
$10.32 P/Share
|
May 29
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+7.43%
|
$1,326,051
$9.84 P/Share
|
May 25
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
138,700
+7.59%
|
$1,248,300
$9.62 P/Share
|